PFG
DGX icon

Piershale Financial Group’s Quest Diagnostics DGX Stock Holding History

Piershale Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-151
Closed -$11K – 145
2016
Q1 		$11K Buy
+151
New +$10.1K 0.01% 77

Other funds holding DGX

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Piershale Financial Group's DGX Position: Q2 2016 in Review

Piershale Financial Group sold out of Quest Diagnostics (DGX) in Q2 2016, closing a stake of 151 shares — an estimated $11K sold.

Piershale Financial Group first reported a position in DGX in Q1 2016 and held it in 1 quarter. The position peaked at $11K in Q1 2016. 558 funds tracked by Wall St. Rank hold DGX as of Q2 2016.

  • Piershale Financial Group reported no remaining Quest Diagnostics position as of Q2 2016 after selling out during the quarter.
  • Piershale Financial Group sold 151 Quest Diagnostics shares in Q2 2016, an estimated $11K.
  • Piershale Financial Group first reported a position in Quest Diagnostics in Q1 2016 and held it in 1 quarter.
  • Piershale Financial Group's Quest Diagnostics position peaked at $11K in Q1 2016.
  • 558 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2016.

Based on Piershale Financial Group's 13F filing for Q2 2016, filed 15 Jul 2016.